Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 8, 2010, Pages 777-781

  Weil, Brian R ^a   Mestek, Michael L ^a   Westby, Christian M ^a   van Guilder, Gary P ^a   Greiner, Jared J ^a   Stauffer, Brian L ^a,b,c   DeSouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Endothelial function; Sleep; Vasoconstriction

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLEEP; SLEEP TIME; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WAIST HIP RATIO;

ANTIHYPERTENSIVE AGENTS; ENDOTHELIN-1; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; SLEEP DEPRIVATION; VASOCONSTRICTION;

EID: 78650218496     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-046     Document Type: Article

References (34)

1. Ayas, N.T., White, D.P., Manson, J.E., Stampfer, M.J., Speizer, F.E., Malhotra, A., and Hu, F.B. 2003. A prospective study of sleep duration and coronary heart disease in women. Arch. Intern. Med. 163(2): 205-209.doi:10.1001/archinte.163.2.205. PMID:12546611.
2. Banks, S., and Dinges, D.F. 2007. Behavioral and physiological consequences of sleep restriction. J. Clin. Sleep Med. 3(5): 519-528. PMID:17803017.
3. Cardillo, C., Kilcoyne, C.M., Waclawiw, M., Cannon, R.O., III, and Panza, J.A. 1999. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension, 33(2): 753-758. PMID:10024340.
4. Cardillo, C., Kilcoyne, C.M., Cannon, R.O., III, and Panza, J.A. 2000. Increased activity of endogenous endothelin in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 36(5): 1483-1488. doi:10.1016/S0735-1097(00)00910-4. PMID:11079646.
5. Cardillo, C., Campia, U., Bryant, M.B., and Panza, J.A. 2002. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation, 106(14): 1783-1787. doi:10. 1161/01.CIR.0000032260.01569.64. PMID:12356630.
6. Dashwood, M.R., and Tsui, J.C. 2002. Endothelin-1 and athero sclerosis: potential complications associated with endothelin receptor blockade. Atherosclerosis, 160(2): 297-304. doi:10. 1016/S0021-9150(01)00586-X. PMID:11849651.
7. Gangwisch, J.E., Heymsfield, S.B., Boden-Albala, B., Buijs, R.M., Kreier, F., Pickering, T.G., et al. 2006. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension, 47(5): 833-839. doi:10.1161/01.HYP.0000217362.34748.e0. PMID: 16585410.
8. Gottlieb, D.J., Punjabi, N.M., Newman, A.B., Resnick, H.E., Redline, S., Baldwin, C.M., and Nieto, F.J. 2005. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch. Intern. Med. 165(8): 863-867.doi:10.1001/archinte. 165.8.863. PMID:15851636.
9. Gottlieb, D.J., Redline, S., Nieto, F.J., Baldwin, C.M., Newman, A.B., Resnick, H.E., and Punjabi, N.M. 2006. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep, 29(8): 1009-1014.PMID:16944668.
10. Hall, M.H., Muldoon, M.F., Jennings, J.R., Buysse, D.J., Flory, J.D., and Manuck, S.B. 2008. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep, 31(5): 635-643. PMID:18517034.
11. Hauri, P.J., and Wisbey, J. 1992. Wrist actigraphy in insomnia. Sleep, 15(4): 293-301. PMID:1519002.
12. Kelly, J.J., and Whitworth, J.A. 1999. Endothelin-1 as a mediator in cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 26(2): 158-161. doi:10.1046/j.1440-1681.1999.03011.x. PMID:10065339.
13. Knutson, K.L., Ryden, A.M., Mander, B.A., and Van Cauter, E. 2006. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch. Intern. Med. 166(16): 1768-1774. doi:10.1001/archinte.166.16.1768. PMID:16983057.
14. Kripke, D.F., Garfinkel, L., Wingard, D.L., Klauber, M.R., and Marler, M.R. 2002. Mortality associated with sleep duration and insomnia. Arch. Gen. Psychiatry, 59(2): 131-136. doi:10.1001/ archpsyc.59.2.131. PMID:11825133.
15. Krum, H., Viskoper, R.J., Lacourciere, Y., Budde, M., and Charlon, V.; Bosentan Hypertension Investigators. 1998. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N. Engl. J. Med. 338(12): 784-790. doi:10.1056/NEJM199803193381202. PMID:9504938.
16. Lerman, A., and Zeiher, A.M. 2005. Endothelial function: cardiac events. Circulation, 111(3): 363-368. doi:10.1161/01.CIR. 0000153339.27064.14. PMID:15668353.
17. Lockley, S.W., Skene, D.J., and Arendt, J. 1999. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J. Sleep Res. 8(3): 175-183. doi:10.1046/j.1365-2869.1999.00155.x. PMID:10476003.
18. Lohman, T.G., Roche, A.F., and Mortorelli, R. 1988. Anthropometric standardization reference manual. Human Kinetics, Champaign, Ill.
19. Lusardi, P., Zoppi, A., Preti, P., Pesce, R.M., Piazza, E., and Fogari, R. 1999. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am. J. Hypertens. 12(1 Pt. 1): 63-68. doi:10.1016/S0895-7061(98)00200-3. PMID:10075386.
20. Malhotra, A., and Loscalzo, J. 2009. Sleep and cardiovascular disease: an overview. Prog. Cardiovasc. Dis. 51(4): 279-284.doi:10.1016/j.pcad.2008.10.004. PMID:19110129.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7): 412-419. doi:10.1007/BF00280883. PMID:3899825.
22. Meier-Ewert, H.K., Ridker, P.M., Rifai, N., Regan, M.M., Price, N.J., Dinges, D.F., and Mullington, J.M. 2004. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 43(4): 678-683.doi:10.1016/j. jacc.2003.07.050. PMID:14975482.
23. Miyauchi, T., and Masaki, T. 1999. Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61(1): 391-415. doi:10.1146/annurev.physiol.61.1.391. PMID:10099694.
24. Nakov, R., Pfarr, E., Eberle, S., and Heatinvestigators; HEAT Investigators. 2002. Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension. Am. J. Hypertens. 15(7 Pt. 1): 583-589. doi:10.1016/S0895-7061(02)02933-3. PMID: 12118903.
25. Patel, S.R., Ayas, N.T., Malhotra, M.R., White, D.P., Schernhammer, E.S., Speizer, F.E., et al. 2004. A prospective study of sleep duration and mortality risk in women. Sleep, 27(3): 440-444. PMID:15164896.
26. National Sleep Foundation. 2009. Sleep in America Poll. National Sleep Foundation, Washington, D.C.
27. Qureshi, A.I., Giles, W.H., Croft, J.B., and Bliwise, D.L. 1997. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology, 48(4): 904-911. PMID:9109875.
28. Sallis, J.F., Haskell, W.L., Wood, P.D., Fortmann, S.P., Rogers, T., Blair, S.N., and Paffenbarger, R.S., Jr. 1985. Physical activity assessment methodology in the Five-City Project. Am. J. Epidemiol. 121(1): 91-106. PMID:3964995.
29. Schiffrin, E.L. 2005. Vascular endothelin in hypertension. Vascul. Pharmacol. 43(1): 19-29. doi:10.1016/j.vph.2005.03.004. PMID: 15955745.
30. Spiegel, K., Leproult, R., and Van Cauter, E. 1999. Impact of sleep debt on metabolic and endocrine function. Lancet, 354(9188): 1435-1439. doi:10.1016/S0140-6736(99)01376-8. PMID:10543671.
31. Taheri, S., Lin, L., Austin, D., Young, T., and Mignot, E. 2004. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 1(3): e62. doi:10.1371/journal.pmed.0010062. PMID:15602591.
32. Touyz, R.M., and Schiffrin, E.L. 2003. Role of endothelin in human hypertension. Can. J. Physiol. Pharmacol. 81(6): 533-541. doi:10.1139/y03-009. PMID:12839265.
33. Van Guilder, G.P., Westby, C.M., Greiner, J.J., Stauffer, B.L., and DeSouza, C.A. 2007. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension, 50(2): 403-409.doi:10.1161/HYPERTENSIONAHA.107.088294. PMID:17576858.
34. Verma, S., Li, S.H., Badiwala, M.V., Weisel, R.D., Fedak, P.W., Li, R.K., et al. 2002. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 105(16): 1890-1896.doi:10.1161/01.CIR. 0000015126.83143.B4. PMID:11997273.